Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in
Home>Products>This Product

MaxDiscovery™ Human IL-3 ELISA Test Kit

Product Description
The MaxDiscovery™ Human IL-3 ELISA Test Kit is designed for quantitative determination of the concentration of human IL-3 in serum, plasma, and cell culture supernatant. Human interleukin 3 (IL-3) is a glycoprotein of 133 amino acids after cleavage of a 19 amino acid signal sequence. It is a pleiotropic factor that can stimulate the proliferation, differentiation, and survival of pluripotent hematopoietic stem cells as well as various lineage-committed progenitors. IL-3 is produced by several cell types including activated human T cells, natural killer cells, mast cells, epithelial cells, stromal cells, keratinocytes, neuronsand astrocytes. At the amino acid level, there is only 29% homology between mouse and human IL-3. Consistent with this lack of homology, the proteins are species-specific in their actions. IL-3 exerts its biological activities through binding to heteromeric transmembrane receptors. It has been shown that IL-3 alone, or acting synergistically with other early acting hematopoietic growth factors including, IL-1, IL-6, stem cell factor, G-CSF, MGDF, and Flt-3 ligand, can support the proliferation of pluripotent hematopoietic stem cells and progenitor cells of various lineages. In addition to its effects on hematopoietic cells, IL-3 can stimulate human endothelial and smooth muscle cell proliferation and motility and can act as a neurotrophic factor with the ability to promote neuronal survival and enhance neurite outgrowth. IL-3-/- mice do appear to exhibit deficiencies in mast cell and basophil development in addition to compromised immunity to parasites and reductions in delayed hypersensitivity reactions.
Product MaxDiscovery™ Human IL-3 ELISA Test Kit
Company BIOO Scientific - Product Directory
Price Request a quote
More Information View company product page
Catalog Number 2117-01
Quantity 1 x 96 wells
Company Logo

BIOO Scientific - Product Directory
3913 Todd Lane Suite 312 Austin, TX 78744, USA

Tel: +1 512-707-8993
Fax: +1 512-707-8122

Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
University of Edinburgh, Selcia Achieve Key Milestones in Drug Development Program
Scientists from the University of Edinburgh, working with Selcia, have successfully passed the 20-month milestone targets of a 30-month Wellcome Trust SDDi £2.5 million project to design novel treatments for sleeping sickness.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
World’s First Therapeutic Venom Database
Open-source library describes nearly 43,000 effects on the human body.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
The Do’s and Don’ts of SPR Experiments
Surface Plasmon Resonance (SPR) is a technique that is becoming more widely used, particularly by anyone who wants to obtain accurate on (association) and off (dissociation) rates for biomolecular binding.
Long-Sought Protein Sensor for the ‘Sixth Sense’ Discovered
In a study led by scientists from The Scripps Research Institute (TSRI)the sensor protein for propioception has been identified.
New Anti-Malarial Drug Screening Model
University of South Florida researchers demonstrate novel chemogenomic profiling to identify drug targets for the most lethal strain of malaria.


Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos